Cy5.5 NHS Ester (Non-Sulfonated): Transforming Near-Infrared Fluorescent Labeling in Molecular Biology

Principle and Setup: Understanding Cy5.5 NHS Ester Chemistry

Cy5.5 NHS ester (non-sulfonated) is a next-generation near-infrared fluorescent dye for biomolecule labeling, specifically engineered for high-sensitivity and deep-tissue imaging. Leveraging its NHS ester chemistry, Cy5.5 NHS ester reacts selectively with primary amine groups on proteins, peptides, and oligonucleotides to form highly stable amide bonds. This robust chemical linkage ensures minimal dye dissociation, which is critical for reliable, long-term imaging in both in vitro and in vivo applications.

Key physicochemical properties include:

• Excitation/emission maxima: 684 nm/710 nm (the classic excitation emission Cy5.5 profile), minimizing background autofluorescence and maximizing signal-to-noise in biological samples.
• Solubility: Highly soluble in DMSO and DMF (≥35.82 mg/mL in DMSO), but with low aqueous solubility, making proper dissolution in organic solvents essential for optimal labeling efficiency.
• Stability: The solid dye is stable for up to 24 months at -20°C in the dark. It should be protected from light and dissolved immediately before use, as it is not stable in solution.

These features make Cy5.5 NHS ester a top-tier amino group labeling reagent and a versatile fluorescent dye for protein conjugation, ideally suited for advanced molecular imaging workflows.

Step-by-Step Workflow: Optimizing Cy5.5 NHS Ester Labeling Protocols

Efficient use of Cy5.5 NHS ester (non-sulfonated) requires attention to detail in reagent preparation, conjugation conditions, and purification. Below is an optimized protocol for labeling proteins, with extensions for peptides and oligonucleotides:

1. Reagent Preparation

• Dissolution: Weigh the required amount of Cy5.5 NHS ester and dissolve in anhydrous DMSO or DMF to prepare a 10–30 mM stock solution. Prepare fresh immediately prior to use.
• Buffer: Use a carbonate or PBS buffer (pH 8.3–8.5) for the conjugation reaction. Avoid buffers containing primary amines (e.g., Tris, glycine) as these compete with the biomolecule for dye reactivity.

2. Conjugation Reaction

• Add protein (or peptide/oligonucleotide) in buffer to a reaction vessel.
• Slowly add the Cy5.5 NHS ester stock solution while gently mixing. A common starting ratio is 3–10 molar equivalents of dye per amine group.
• Incubate at room temperature (20–25°C) for 30–60 minutes, protected from light.

3. Purification

• Remove free dye using size-exclusion chromatography, dialysis, or spin columns (MWCO 3–10 kDa depending on the biomolecule).
• Confirm successful labeling by measuring absorbance at 684 nm and calculating the degree of labeling (DOL).

4. Storage

• Store the labeled conjugate at 4°C, protected from light. For long-term storage, aliquot and freeze at -20°C.

For a comprehensive troubleshooting guide and protocol Q&A, see the reliability-focused article which addresses common challenges in cell viability, proliferation, and cytotoxicity assays using Cy5.5 NHS ester (non-sulfonated).

Advanced Applications and Comparative Advantages

Cy5.5 NHS ester (non-sulfonated) is at the forefront of near-infrared fluorescence imaging, enabling a host of advanced applications that demand high sensitivity, low background, and deep tissue penetration. Notably, its use as a tumor imaging agent and in in vivo fluorescence imaging workflows distinguishes it from traditional visible-range dyes.

Optical Imaging of Tumors and Deep Tissue

In preclinical and translational oncology, Cy5.5 NHS ester has demonstrated exceptional performance for optical imaging of tumors. Due to its emission in the NIR window (710 nm), it penetrates several millimeters into tissue, offering superior contrast and minimal autofluorescence. For example, in orthotopic tumor models, Cy5.5-labeled antibodies or nanoparticles enable real-time delineation of tumor margins, guiding resection or therapy monitoring.

Enabling Non-Invasive Neuromodulation Imaging

A recent reference study (Li et al., 2025) leveraged NIR fluorescent labeling to monitor the biodistribution and brain targeting of biomimetic piezo-nanoplatforms for non-invasive epilepsy treatment. Such advanced nanoplatforms, when labeled with Cy5.5 NHS ester, can be tracked in vivo to assess pharmacokinetics, targeting specificity, and therapeutic efficacy, all without surgical intervention. This supports the growing intersection of nanomedicine, neuromodulation, and molecular imaging enabled by robust NIR fluorophores.

Comparative Perspective

• Cy5.5 NHS ester (non-sulfonated): Near-Infrared Fluorescence for Biomolecule Labeling provides a foundational overview, emphasizing its low background and high specificity in labeling proteins and nucleic acids. This article complements the current discussion by offering verifiable application notes for molecular and tumor imaging workflows.
• Rewriting the Playbook: Near-Infrared Labeling Technologies extends these concepts to cutting-edge translational research, highlighting the synergy between Cy5.5 NHS ester labeling and emerging diagnostic strategies involving the tumor microenvironment and microbiome modulation.
• Advanced Near-Infrared Dye for Biomolecule Labeling delves into the specificity and photostability of Cy5.5 NHS ester across a range of sample types, reinforcing its unique value for precision oncology and high-sensitivity imaging.

Collectively, these resources underscore the versatility and reliability of Cy5.5 NHS ester in both standard and next-generation imaging paradigms.

Troubleshooting and Protocol Optimization Tips

Even the most robust labeling dyes can present workflow challenges. Here are common pitfalls and expert strategies for optimizing Cy5.5 NHS ester-based labeling:

• Low Conjugation Efficiency: If the degree of labeling is suboptimal, ensure the dye is fully dissolved in DMSO or DMF and added to the biomolecule solution immediately. Increase the dye-to-protein ratio incrementally, but avoid excessive over-labeling, which can compromise protein function.
• Precipitation or Aggregation: Slow precipitation may indicate excessive organic solvent or suboptimal buffer conditions. Maintain organic co-solvent below 10% (v/v) and ensure buffer pH is 8.3–8.5. If aggregation persists, reduce dye equivalents or shorten reaction time.
• High Background Fluorescence: Incomplete removal of free dye is a leading cause. Employ size-exclusion chromatography or high-efficiency spin columns, and validate purity by spectrophotometric analysis (absence of unbound dye at 684 nm).
• Photobleaching or Signal Loss: Cy5.5 NHS ester is photostable, but labeled samples should be protected from prolonged light exposure. Store conjugates in lightproof containers at appropriate temperatures.
• Batch Variability: Always use freshly prepared dye stocks and maintain consistent reaction conditions. For troubleshooting batch-to-batch differences, refer to the Q&A and protocol optimization insights in the practical guide.

For highly sensitive workflows such as fluorescent labeling in molecular biology or multiplexed imaging, verify the cy5.5 excitation emission profile post-labeling to confirm dye integrity and signal intensity.

Future Outlook: Cy5.5 NHS Ester in Next-Generation Molecular Imaging

The need for precise, non-invasive, and high-resolution imaging agents will only increase as life sciences research continues to evolve. Cy5.5 NHS ester (non-sulfonated), offered by APExBIO, is uniquely positioned to meet these demands, driving innovation in areas such as:

• Real-time in vivo tracking of therapeutic nanoparticles, stem cells, or gene editing systems, leveraging enhanced NIR penetration for multi-organ and whole-body imaging.
• Synergistic neuromodulation and drug delivery studies, as demonstrated in the recent epilepsy nanoplatform research, where NIR-labeled constructs enable both therapy and monitoring.
• Multiplexed diagnostics and single-cell analytics, where the sharp emission and high brightness of Cy5.5 facilitate simultaneous detection of multiple targets with minimal spectral overlap.
• Emerging clinical translation in fluorescence-guided surgery, targeted drug delivery assessments, and personalized medicine.

As the field advances, the integration of Cy5.5 NHS ester with other molecular tools—such as piezoelectric nanomaterials, optogenetic actuators, and advanced biosensors—will open new horizons for non-invasive, precision-guided research and therapy.

Conclusion

Cy5.5 NHS ester (non-sulfonated) represents the gold standard for near-infrared fluorescent dye for biomolecule labeling, bringing together ease of use, exceptional optical properties, and robust conjugation chemistry. Its proven track record in tumor imaging, in vivo fluorescence imaging, and advanced molecular biology workflows makes it an indispensable tool for the modern life sciences laboratory. For detailed product specifications and ordering information, visit the Cy5.5 NHS ester (non-sulfonated) product page from APExBIO.